Observational Study Evaluating Safety and Performance of IDI Dental Implant Systems in Subjects Followed for 18 Months.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

121 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-09

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-Market Clinical Follow-Up to evaluate the safety and performance of IDI dental implant systems : confirmation of osseointegration of the different implants at the loading visit (between 2 and 6 months after surgery).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Study to Evaluate Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants

NCT01878331

Jaw, Edentulous

COMPLETED

An Observational Clinical Study of the T3 Dental Implant System

NCT05062863

Edentulous Jaw

ACTIVE_NOT_RECRUITING

Impact of Removable Versus Fixed Implant-supported Prostheses in Oral Health Quality of Life for Edentulous Patients

NCT05162963

Complete Edentulism

UNKNOWN NA

Implant Stability Changes In Dental Implants Installed By Osseodensification and Conventional Methods

NCT05390996

Dental Implant Stability

UNKNOWN NA

Peri-implant Health of Dental Implants in the Posterior Region; an Evaluation After 10 Years

NCT05650099

Missing Teeth

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the present study is to carry out post-marketing clinical monitoring of the medical device used in accordance with the instructions for use according to a medical strategy intended for the person who is suitable for this research which is not fixed in advance by an investigation plan and is part of the current practice of the surgeon.

This is a comparative, prospective, multicenter observational study

The osteointegration reached between 2 and 6 months after surgery will be evaluated by clinical and radiological examinations:

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Prosthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dental prothesis

5 ranges of implants can be used : IDAll, IDBio, IDCam, IDMax, ID3

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject receiving an insertion of an aesthetic and functional oral prosthesis on IDI implant systems (IDAll, IDBio, IDCam, IDMax or ID3) for at least one of the following indications:

* Single, partial or complete edentulousness
* Stabilization of a removable prosthesis
* Subject having received an information sheet on the study and having indicated their non-objection before starting the procedures specific to the protocol.
* ASA score (American Society of Anesthesiologists) \<3.
* If a recent extraction has been performed at the site of the implantation area, the healing period should be at least 2 months.
* Sufficient bone volume (minimum 4mm) to accommodate dental implants.

Exclusion Criteria

* Pregnant or breastfeeding woman.
* Inability of the subject to maintain reasonable oral hygiene in accordance with study requirements.
* Parafunctional habits, such as bruxism or temporomandibular joint disease.
* Different pathologies of the oral mucosa such as: benign mucous pemphigoid, desquamative gingivitis, malignant tumor of the oral cavity, bolus erosive diseases of the oral mucosa.
* Disorders of bone metabolism.
* Untreated, unmanaged caries and / or periodontal disease.
* Need for simultaneous bone grafting and / or sinus lift in the intended implant area.
* Medical history making insertion of the implant unfavorable.
* Lack of cooperation. Subject may not comply with study procedures.
* Heavy use of tobacco (more than 10 cigarettes per day), drugs and / or alcohol.
* Treatment with bisphosphonates, steroids or anticonvulsants.
* Unbalanced diabetes.
* Subject receiving radiotherapy, chemotherapy or any other immunosuppressive treatment. Subjects who received radiation therapy to the head and neck area at any time should not be included.
* Congenital or acquired (HIV positive) diseases that compromise the immune system.
* Uncontrolled bleeding disorders such as: haemophilia, thrombocytopenia, granulocytopenia.
* Renal failure.
* Organ transplant recipient.
* Malignant diseases.
* Psychotic illnesses.
* Hypersensitivity to one of the components of the implant in general and to titanium in particular. It is the surgeon's responsibility to ensure that the subject does not have known allergies to any of the components of the material listed on the product label.
* Sports or physical activities including violent shocks.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No